EUVIMEDEUVIMED entdecken
Crossref

Pharmacovigilance of Lutetium Lu-177 PSMA-617 Versus PARP Inhibitors in metastatic Castration Resistant Prostate Cancer: A FAERS-Based Analysis

M.A. Ganiyani, A. Sheraz, D.H. Syed, A. Nagendran, A. Pon Avudaiappan, A. Abdalla, M. Pustake, A. Kaiser, M. Manoharan, M.P. Mehta, R. Garje

International Journal of Radiation Oncology*Biology*Physics · 2026-05 · 125 (1) · e14

DOI: 10.1016/j.ijrobp.2026.02.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-05. Verfasst von M.A. Ganiyani und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ganiyani, M., Sheraz, A., Syed, D., Nagendran, A., Avudaiappan, A. P., Abdalla, A., Pustake, M., Kaiser, A., Manoharan, M., Mehta, M., & Garje, R. (2026). Pharmacovigilance of Lutetium Lu-177 PSMA-617 Versus PARP Inhibitors in metastatic Castration Resistant Prostate Cancer: A FAERS-Based Analysis. International Journal of Radiation Oncology*Biology*Physics, 125(1), e14. https://doi.org/10.1016/j.ijrobp.2026.02.030

Vancouver

Ganiyani M, Sheraz A, Syed D, Nagendran A, Avudaiappan AP, Abdalla A, et al. Pharmacovigilance of Lutetium Lu-177 PSMA-617 Versus PARP Inhibitors in metastatic Castration Resistant Prostate Cancer: A FAERS-Based Analysis. International Journal of Radiation Oncology*Biology*Physics. 2026;125(1):e14. doi:10.1016/j.ijrobp.2026.02.030

BibTeX
@article{Ganiyani2026,
  author = {Ganiyani, M.A. and Sheraz, A. and Syed, D.H. and Nagendran, A. and Avudaiappan, A. Pon and Abdalla, A. and Pustake, M. and Kaiser, A. and Manoharan, M. and Mehta, M.P. and Garje, R.},
  title = {Pharmacovigilance of Lutetium Lu-177 PSMA-617 Versus PARP Inhibitors in metastatic Castration Resistant Prostate Cancer: A FAERS-Based Analysis},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {125},
  number = {1},
  pages = {e14},
  doi = {10.1016/j.ijrobp.2026.02.030}
}
Kostenlos starten →